List of works - Gamal Esmat

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

scientific article

Antiretroviral therapy optimisation in the time of COVID-19: Is it really different in North and South Africa?

scientific article published on 30 July 2020

Antischistosomal therapy: Current status and recent developments.

scientific article published in March 2009

Association of HCV with diabetes mellitus: an Egyptian case-control study.

scientific article

COVID-19 crisis effect on HIV service delivery in Egypt: Hard times or blessings in disguise?

scientific article published on 09 December 2020

Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.

scientific article published in April 2012

Estrogen-related MxA transcriptional variation in hepatitis C virus-infected patients ⬇️

scientific article published on September 3, 2011

Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients

scientific article published on 20 April 2011

HLA Tissue Typing Has No Effect on the Outcome of Patients Undergoing a Living-donor Liver Transplant: A Single-center Experience in Egypt ⬇️

scientific article published on April 1, 2012

Hepatic and intestinal schistosomiasis: review

scientific article

Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors

scientific article

How to optimize HCV therapy in genotype 4 patients.

scientific article published on February 2013

Human cytomegalovirus infection inhibits response of chronic hepatitis-C-virus-infected patients to interferon-based therapy.

scientific article

Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma.

scientific article

NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients

scientific article

Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians.

scientific article

Quality of life of Egyptian donors after living-related liver transplantation.

scientific article

Reproducibility of liver stiffness measurements in hepatitis C virus (HCV)-infected patients in Egypt.

scientific article published on 24 January 2011

Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4.

scientific article

Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children ⬇️

scientific article published on September 15, 2011

Role of Helicobacter pylori in patients with HCV-related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: possible association with disease progression.

scientific article published on 28 December 2011

Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4

scientific article

Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy.

scientific article

Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.

scientific article

The future for the treatment of genotype 4 chronic hepatitis C.

scientific article published on February 2012

Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response.

scientific article published on 20 May 2011

miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.

scientific article

List of works by Gamal Esmat

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

Antiretroviral therapy optimisation in the time of COVID-19: Is it really different in North and South Africa?

Antischistosomal therapy: Current status and recent developments.

Association of HCV with diabetes mellitus: an Egyptian case-control study.

COVID-19 crisis effect on HIV service delivery in Egypt: Hard times or blessings in disguise?

Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.

Estrogen-related MxA transcriptional variation in hepatitis C virus-infected patients ⬇️

Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients

HLA Tissue Typing Has No Effect on the Outcome of Patients Undergoing a Living-donor Liver Transplant: A Single-center Experience in Egypt ⬇️

Hepatic and intestinal schistosomiasis: review

Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors

How to optimize HCV therapy in genotype 4 patients.

Human cytomegalovirus infection inhibits response of chronic hepatitis-C-virus-infected patients to interferon-based therapy.

Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma.

NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients

Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians.

Quality of life of Egyptian donors after living-related liver transplantation.

Reproducibility of liver stiffness measurements in hepatitis C virus (HCV)-infected patients in Egypt.

Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4.

Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children ⬇️

Role of Helicobacter pylori in patients with HCV-related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: possible association with disease progression.

Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4

Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy.

Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.

The future for the treatment of genotype 4 chronic hepatitis C.

Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response.

miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.